| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACLY
|
ATP citrate lyase
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APITD1
|
apoptosis-inducing, TAF9-like domain 1
|
|
APOB
|
apolipoprotein B
|
|
APOC1
|
apolipoprotein C-I
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome
|
|
ATF3
|
activating transcription factor 3
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
AURKA
|
aurora kinase A
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BPY2
|
basic charge, Y-linked, 2
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCND1
|
cyclin D1
|
|
CD19
|
CD19 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHGA
|
chromogranin A
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CREBBP
|
CREB binding protein
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP4V2
|
cytochrome P450, family 4, subfamily V, polypeptide 2
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DLX5
|
distal-less homeobox 5
|
|
DLX6
|
distal-less homeobox 6
|
|
DRD2
|
dopamine receptor D2
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDN1
|
endothelin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
ENG
|
endoglin
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ETV6
|
ets variant 6
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHIT
|
fragile histidine triad
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXN1
|
forkhead box N1
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GH1
|
growth hormone 1
|
|
GNAS
|
GNAS complex locus
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPSE
|
heparanase
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTT
|
huntingtin
|
|
IGH
|
immunoglobulin heavy locus
|
|
IL10
|
interleukin 10
|
|
INHA
|
inhibin, alpha
|
|
INS
|
insulin
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLK1
|
kallikrein 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LOR
|
loricrin
|
|
MAOA
|
monoamine oxidase A
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPT
|
microtubule-associated protein tau
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMS19
|
MMS19 nucleotide excision repair homolog (S. cerevisiae)
|
|
MSN
|
moesin
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOTCH1
|
notch 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NUP98
|
nucleoporin 98kDa
|
|
OBSCN
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX2
|
paired box 2
|
|
PAX6
|
paired box 6
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PHF6
|
PHD finger protein 6
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PLG
|
plasminogen
|
|
PLP1
|
proteolipid protein 1
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRNP
|
prion protein
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
RANBP1
|
RAN binding protein 1
|
|
RARB
|
retinoic acid receptor, beta
|
|
RDX
|
radixin
|
|
RETN
|
resistin
|
|
RTN4R
|
reticulon 4 receptor
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STGC3
|
uncharacterized STGC3
|
|
STOM
|
stomatin
|
|
TAC1
|
tachykinin, precursor 1
|
|
TBX1
|
T-box 1
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|
|
USP9Y
|
ubiquitin specific peptidase 9, Y-linked
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VWF
|
von Willebrand factor
|
|
WT1
|
Wilms tumor 1
|
